Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb study of ropivacaine versus adrenaline-lidocaine for pain control in third molar extraction surgery
2011-000535-86Phase 2Completed
- Sponsor
- CHU Ambroise Paré
- Start
- Feb 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ropivacaine in None and impacted third molar (I3M) (2 arms), sponsored by CHU Ambroise Paré. Primary endpoints: Sedation and analgesic use during surgery and postoperative period and Patient complaints. Started Feb 2011; status: completed.
02
Drugs
ropivacaine
03
Conditions
impacted third molar (I3M)
Beyond the preview
Go deeper on 2011-000535-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000535-86.